Neuropsychiatric genetics laboratory

CCRN and WAIMR are working together to explore the genetic factors that may influence an individual’s susceptibility to disabling illnesses such as schizophrenia, Parkinson’s disease and heroin dependence.

Research projects

• Identification of schizophrenia susceptibility genes
• Association of candidate genes for schizophrenia in chromosome 3p26.2-25.3
• Protein expression of dysbindin, PIP5K2a, AKT in lymphoblast cell lines from schizophrenic patients
• Heroin dependence in Western Australia
• Dysbindin (DTNBP1) mRNA expression in schizophrenic patients and controls
• Parkinson’s disease and comorbidity
• WAIMR genetics laboratory (external link)

Honours and postgraduate studies

• Investigation of functional implications of a schizophrenia-associated non-synonymous nucleotide exchange in the gene for the Phosphatidylinositol, 5 kinase 2alpha (PIP5K2A) gene

Contacts

Professor Dieter Wildenauer +61 8 9347 6782
Dr Sibylle Schwab +61 8 9346 2711 (2981)